Overview
Jennifer Glass is a Surgical Oncologist in Atlanta, Georgia. Dr. Glass is rated as an Experienced provider by MediFind in the treatment of Rhabdomyosarcoma. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
550 Peachtree Street Northeast, MedicalOfficeTower, Atlanta, GA 30308
Winship Cancer Institute At Emory Midtown
Kenneth Cardona is a Surgical Oncologist in Atlanta, Georgia. Dr. Cardona has been practicing medicine for over 24 years and is rated as an Elite provider by MediFind in the treatment of Rhabdomyosarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Retroperitoneal Liposarcoma, Pancreaticoduodenectomy, and Pancreatectomy.
Emory Winship Cancer Institute
Keith Delman is a Surgical Oncologist in Atlanta, Georgia. Dr. Delman has been practicing medicine for over 30 years and is rated as a Distinguished provider by MediFind in the treatment of Rhabdomyosarcoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Rhabdomyosarcoma Embryonal, Lymphadenectomy, and Endoscopy.
Winship Cancer Institute At Emory Saint Joseph's Hospital
David Kooby is a Surgical Oncologist in Atlanta, Georgia. Dr. Kooby has been practicing medicine for over 32 years and is rated as an Elite provider by MediFind in the treatment of Rhabdomyosarcoma. His top areas of expertise are Pancreatic Cancer, Stomach Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer